Article
Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of Parkinson’s disease
2022-02-11
Abstract excerpt
<h4>ABSTRACT</h4> The lysosomal cysteine hydrolase N -acylethanolamine acid amidase (NAAA) deactivates the lipidderived mediator palmitoylethanolamide (PEA), an endogenous PPAR-α agonist that is critically involved in the control of inflammation and nociception. In this study, we asked whether NAAA-regulated PEA signaling might contribute to the pathogenesis of Parkinson’s disease (PD), a neurodegenerative disor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93f77874-7671-5330-8f73-0e2a764a1bca
- DOI
- 10.1101/2022.02.10.479850
